UMED participated in the IBK Innovation Pavilion at CES 2026 in Las Vegas, USA, showcasing its automated bladder irrigation system 'UroRinse™ Light' on the global stage and confirming high interest from both domestic and international markets.

At CES 2026, UMED, participating in the IBK ChangGong Pavilion, drew global attention by winning a Digital Health Innovation Award for its LLM-based urology AI healthcare platform.

At CES 2026, UMED, a Digital Health Innovation Award winner, showcased its automated bladder irrigation system UroRinse Light, representing the shift toward non-invasive, remote, and everyday healthcare solutions.

At CES 2026, UMED, a CES Innovation Award winner in Digital Health, showcased its automated bladder irrigation system, highlighting the global competitiveness of Korean healthcare technology.

Umed, a digital healthcare company specializing in urology, captured global attention by winning the CES Innovation Awards.

UMED participated in the “IBK Changgong CES 2026 Kick-Off” event organized by IBK Industrial Bank of Korea’s startup incubation platform, IBK Changgong.

BTB Ventures, which has operated the Gyeongnam-style Startup Accelerating Support Program for three consecutive years since 2023, cited UMED’s CES 2026 Innovation Award as a meaningful achievement of the 2025 program.

At CES 2026, UMED’s AI-powered bladder irrigation medical device received an Innovation Award.

At the Southeast Angelwave IR Camp, UMED was selected as an Outstanding Startup, earning recognition for its UroRinse technology.

UMED’s automated bladder irrigation system, UroRinse™ Light, has been selected as an Innovation Award honoree in the Digital Health category at CES 2026, the world’s largest technology exhibition.

UMED’s automated bladder irrigation system, UroRinse® Light, has received domestic medical device manufacturing certification, officially validating its safety and technological excellence.

UMED and People&Technology have signed an MOU for collaboration in urologic IoMT, aiming to build a smart medical platform by 2027.

UMED's World-First Automated Intermittent Bladder Irrigation System 'UroRinse®' Featured in Significant International Journal Following Successful Preclinical Study Collaborative Study with UCSD Proves Preventive Effect Against Catheter-Associated Urinary Tract Infections (CAUTIs)

UMED participated in the “2025 Startup-BuS Joint IR” event, where it shared its business strategy and technological vision.

UMED was selected for the 2025 Gyeongnam Startup Acceleration Support Program, recognizing its potential for global expansion.

UMED, based in Gimhae, is gaining attention in the medical device field by developing the automated bladder irrigation system ‘UroRinse’ through the Startup Leap Package.

Umed presented its collaboration achievements with Samsung Heavy Industries at the ‘2024 Startup Leap Package’ case-sharing event. The company was recognized for its technological capabilities and open innovation performance.

UMED has been selected as a target company for the corporate relocation project promoted by Ulsan City and Ulsan Technopark. As a technology-based small but strong enterprise, UMED is in the process of relocating to Ulsan.

UMED has been selected as one of the 10 leading technology innovation companies by the city of Gimhae.

UMED participated in the Gyeongnam High-Tech Zone IR Road Trip event, where the company presented its technology and received mentoring to attract investment.

UMED was founded by Professor Park Myungchan of Inje University and has been selected for a technology transfer commercialization program.

Filler-specialized company BioPlus (CEO Hyun-Gyu Jung) announced on the 26th that it had signed a memorandum of understanding (MOU) with urethral catheter specialist UroAll to jointly develop a medical device composed of a urethral catheter with drug-eluting capabilities and a drug called InterBlock to prevent re-stricture of the urethra.